Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Current Opinion in Investigational Drugs (London, England : 2000)|November 19, 2003
ONO-2506. OnoTomas de PaulisIdrugs : the Investigational Drugs Journal|March 14, 2007
Drug evaluation: Vilazodone--a combined SSRI and 5-HT1A partial agonist for the treatment of depressionTomas de PaulisCurrent Opinion in Investigational Drugs (London, England : 2000)|January 11, 2007
Drug evaluation: Lymphoseek - Neoprobe's sentinel lymph node imaging agent for use in cancer patientsTomas de PaulisCurrent Opinion in Investigational Drugs (London, England : 2000)|March 11, 2003
Sumanirole PharmaciaTomas de PaulisCurrent Opinion in Investigational Drugs (London, England : 2000)|February 1, 2007
Drug evaluation: PRX-00023, a selective 5-HT1A receptor agonist for depressionTomas de PaulisCurrent Pharmaceutical Design|February 7, 2003
The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brainTomas de PaulisCurrent Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Perospirone (Sumitomo Pharmaceuticals)Tomas de PaulisThe Journal of Nutritional Biochemistry|December 21, 2004
Antioxidant effects of dihydrocaffeic acid in human EA.hy926 endothelial cellsJunjun Huang, Tomas de Paulis, James M MayFood Research International (Ottawa, Ont.)|October 3, 2021
Three centuries on the science of coffee authenticity controlThiago Ferreira, Leticia Galluzzi, Tomas de Paulis, et al.Journal of Agricultural and Food Chemistry|March 3, 2005
Effect of roasting on the formation of chlorogenic acid lactones in coffeeAdriana Farah, Tomas de Paulis, Luiz C Trugo, et al.Pageof 3